OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

Despite many advances in oncology, almost all patients with pancreatic cancer (PC) die of the disease. Molecularly targeted agents are offering hope for their potential role in helping translate the improved activity of combination chemotherapy into improved survival. Heat shock protein 27 (Hsp27) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baylot, V, Andrieu, C, Katsogiannou, M, Taieb, D, Garcia, S, Giusiano, S, Acunzo, J, Iovanna, J, Gleave, M, Garrido, C, Rocchi, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219088/
https://www.ncbi.nlm.nih.gov/pubmed/22012255
http://dx.doi.org/10.1038/cddis.2011.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219088/
https://www.ncbi.nlm.nih.gov/pubmed/22012255
http://dx.doi.org/10.1038/cddis.2011.104

Ejemplares similares